Question: Pegaptanib sodium injection (brand name Macugen) is an anti-angiogenic medicine for the treatment of neovascular (wet) age-related macular degeneration (AMD), it was licensed in 2000 to EyeTech Pharmaceuticals, now called what, an American pharmaceutical company based in Long Island, New York with facilities in Colorado, New Jersey and the United Kingdom?
Sentence (from "Pegaptanib"): Approval was granted by the U.S. Food and Drug Administration (FDA) in December 2004.
Relevant evidence: No